Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors

被引:29
作者
Arias, Hugo R. [1 ]
Feuerbach, Dominik [2 ]
Bhumireddy, Pankaj [3 ]
Ortells, Marcelo O. [4 ,5 ]
机构
[1] Midwestern Univ, Coll Pharm, Dept Pharmaceut Sci, Glendale, AZ USA
[2] Novartis Inst Biomed Res, Basel, Switzerland
[3] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA USA
[4] Univ Moron, Fac Med, Moron, Argentina
[5] Univ Moron, CONICET, Moron, Argentina
关键词
Nicotinic acetylcholine receptors; Serotonin selective reuptake inhibitors; Conformational states; Ca2+ influx; Radioligand binding; Molecular modeling; DIFFERENT CONFORMATIONAL STATES; MOLECULAR-MECHANISMS; TRICYCLIC ANTIDEPRESSANTS; QUINACRINE BINDING; ION-CHANNEL; FLUOXETINE; DYNAMICS; MUSCLE; DIZOCILPINE; ANTAGONISTS;
D O I
10.1016/j.biocel.2010.01.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Functional and structural approaches were used to examine the inhibitory mechanisms and binding site location for fluoxetine and paroxetine, two serotonin selective reuptake inhibitors, on nicotinic acetylcholine receptors (AChRs) in different conformational states. The results establish that: (a) fluoxetine and paroxetine inhibit h alpha 1 beta 1 gamma delta AChR-induced Ca2+ influx with higher potencies than dizocilpine. The potency of fluoxetine is increased similar to 10-fold after longer pre-incubation periods, which is in agreement with the enhancement of [H-3]cytisine binding to resting but activatable Torpedo AChRs elicited by these antidepressants, (b) fluoxetine and paroxetine inhibit the binding of the phencyclidine analog piperidyl-3,4(-3)H(N)]-(N-(1-(2 thienyl)cyclohexyl)-3,4-piperidine to the desensitized Torpedo AChR with higher affinities compared to the resting AChR, and (c) fluoxetine inhibits [H-3]dizocilpine binding to the desensitized AChR, suggesting a mutually exclusive interaction. This is supported by our molecular docking results where neutral dizocilpine and fluoxetine and the conformer of protonated fluoxetine with the highest LUDI score interact with the domain between the valine (position 13') and leucine (position 9') rings. Molecular mechanics calculations also evidence electrostatic interactions of protonated fluoxetine at positions 20', 21', and 24'. Protonated dizocilpine bridges these two binding domains by interacting with the valine and outer ( position 20') rings. The high proportion of protonated fluoxetine and dizocilpine calculated at physiological pH suggests that the protonated drugs can be attracted to the channel mouth before binding deeper within the AChR ion channel between the leucine and valine rings, a domain shared with phencyclidine, finally blocking ion flux and inducing AChR desensitization. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:712 / 724
页数:13
相关论文
共 48 条
[1]   Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function [J].
Albuquerque, Edson X. ;
Pereira, Edna F. R. ;
Alkondon, Manickavasagom ;
Rogers, Scott W. .
PHYSIOLOGICAL REVIEWS, 2009, 89 (01) :73-120
[2]   MEPROADIFEN ENHANCES ACTIVATION AND DESENSITIZATION OF THE ACETYLCHOLINE RECEPTOR-IONIC CHANNEL COMPLEX (ACHR) - SINGLE CHANNEL STUDIES [J].
ARACAVA, Y ;
ALBUQUERQUE, EX .
FEBS LETTERS, 1984, 174 (02) :267-274
[3]   The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor [J].
Arias, HR .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1997, 1347 (01) :9-22
[4]   Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors [J].
Arias, HR ;
Bhumireddy, P ;
Spitzmaul, G ;
Trudell, JR ;
Bouzat, C .
BIOCHEMISTRY, 2006, 45 (07) :2014-2026
[5]   Noncompetitive antagonist binding sites in the Torpedo nicotinic acetylcholine receptor ion channel.: structure-activity relationship studies using adamantane derivatives [J].
Arias, HR ;
Trudell, JR ;
Bayer, EZ ;
Hester, B ;
McCardy, EA ;
Blanton, MP .
BIOCHEMISTRY, 2003, 42 (24) :7358-7370
[6]   Allosterically linked noncompetitive antagonist binding sites in the resting nicotinic acetylcholine receptor ion channel [J].
Arias, HR ;
McCardy, EA ;
Bayer, EZ ;
Gallagher, MJ ;
Blanton, MP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 403 (01) :121-131
[7]   Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor [J].
Arias, HR ;
Mccardy, EA ;
Blanton, MP .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1051-1060
[8]  
ARIAS HR, 2006, BIOL BIOPHYSICAL ASP, P1
[9]   Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors [J].
Arias, Hugo R. ;
Bhumireddy, Pankaj ;
Bouzat, Cecilia .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (08) :1254-1276
[10]   Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions? [J].
Arias, Hugo R. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (11) :2098-2108